Literature DB >> 10651714

Ichthyosis follicularis with alopecia and photophobia in a mother and daughter.

K C Sato-Matsumura1, T Matsumura, M Kumakiri, K Hosokawa, H Nakamura, H Kobayashi, A Ohkawara.   

Abstract

A mother and daughter having ichthyosis follicularis with alopecia and photophobia (IFAP) are reported, with histopathological and electron microscopic findings. We have followed the clinical course of the mother for 26 years since she was 5 years old, and the daughter since birth. They have had almost all the classical and some of the minor symptoms of IFAP, including severe photophobia, extensive non-inflammatory follicular hyperkeratosis, generalized non-scarring alopecia, hyperkeratosis of the extensor aspect of the four extremities, nail deformity and recurrent cheilitis. In addition, their facial appearance greatly resembles that of previously reported patients. A consistent feature in the mother was florid keratotic inflammatory eruptions on the genital region during each of her pregnancies, which rapidly improved after the delivery. Skin biopsy of the genital lesion showed marked acanthosis with dyskeratosis and spongiotic changes. The electron microscopic examination of diseased skin showed damaged desmosomes with spongiosis. No obvious changes were found in normal appearing skin.

Entities:  

Mesh:

Year:  2000        PMID: 10651714     DOI: 10.1046/j.1365-2133.2000.03260.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  Mutations in SREBF1, Encoding Sterol Regulatory Element Binding Transcription Factor 1, Cause Autosomal-Dominant IFAP Syndrome.

Authors:  Huijun Wang; Aytaj Humbatova; Yuanxiang Liu; Wen Qin; Mingyang Lee; Nicole Cesarato; Fanny Kortüm; Sheetal Kumar; Maria Teresa Romano; Shangzhi Dai; Ran Mo; Sugirthan Sivalingam; Susanne Motameny; Yuan Wu; Xiaopeng Wang; Xinwu Niu; Songmei Geng; Dorothea Bornholdt; Peter M Kroisel; Gianluca Tadini; Scott D Walter; Fabian Hauck; Katta M Girisha; Anne-Marie Calza; Armand Bottani; Janine Altmüller; Andreas Buness; Shuxia Yang; Xiujuan Sun; Lin Ma; Kerstin Kutsche; Karl-Heinz Grzeschik; Regina C Betz; Zhimiao Lin
Journal:  Am J Hum Genet       Date:  2020-06-03       Impact factor: 11.025

2.  IFAP syndrome is caused by deficiency in MBTPS2, an intramembrane zinc metalloprotease essential for cholesterol homeostasis and ER stress response.

Authors:  Frank Oeffner; Gayle Fischer; Rudolf Happle; Arne König; Regina C Betz; Dorothea Bornholdt; Ulrike Neidel; María del Carmen Boente; Silke Redler; Javier Romero-Gomez; Aïcha Salhi; Angel Vera-Casaño; Christian Weirich; Karl-Heinz Grzeschik
Journal:  Am J Hum Genet       Date:  2009-04       Impact factor: 11.025

Review 3.  Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome.

Authors:  Hala Mégarbané; André Mégarbané
Journal:  Orphanet J Rare Dis       Date:  2011-05-21       Impact factor: 4.123

4.  Meibomian gland dysfunction in a case of ichthyosis follicularis with alopecia and photophobia syndrome.

Authors:  Tarannum Fatima; Umang Mathur; Manisha Acharya
Journal:  Indian J Ophthalmol       Date:  2014-03       Impact factor: 1.848

5.  Ichthyosis Follicularis, Alopecia, and Photophobia Syndrome.

Authors:  Sunder Nagakeerthana; Murugaiyan Rangaraj; Kaliaperumal Karthikeyan
Journal:  Int J Trichology       Date:  2017 Apr-Jun

Review 6.  MBTPS2, a membrane bound protease, underlying several distinct skin and bone disorders.

Authors:  Natarin Caengprasath; Thanakorn Theerapanon; Thantrira Porntaveetus; Vorasuk Shotelersuk
Journal:  J Transl Med       Date:  2021-03-20       Impact factor: 5.531

7.  S1P defects cause a new entity of cataract, alopecia, oral mucosal disorder, and psoriasis-like syndrome.

Authors:  Fuying Chen; Cheng Ni; Xiaoxiao Wang; Ruhong Cheng; Chaolan Pan; Yumeng Wang; Jianying Liang; Jia Zhang; Jinke Cheng; Y Eugene Chin; Yi Zhou; Zhen Wang; Yiran Guo; She Chen; Stephanie Htun; Erin F Mathes; Alejandra G de Alba Campomanes; Anne M Slavotinek; Si Zhang; Ming Li; Zhirong Yao
Journal:  EMBO Mol Med       Date:  2022-04-01       Impact factor: 14.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.